Real-world clinical effectiveness and safety of vedolizumab and ustekinumab in biologic-naive patients with Crohn's disease: Results from the EVOLVE Expansion study

被引：0
|
作者：
Ferrante, M. [1 ]
Christensen, B. [2 ,3 ]
Bressler, B. [4 ]
Brett, N. [5 ]
Bassel, M. [5 ]
Kamble, P. [6 ]
Adsul, S. [6 ]
Gianchetti, L. [7 ]
Scharl, M. [8 ]
机构：
[1] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
[2] Royal Melbourne Hosp, Dept Gastroenterol, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[4] St Pauls Hosp, Vancouver, BC, Canada
[5] Thermo Fisher Sci, PPD, Montreal, PQ, Canada
[6] Takeda Pharmaceut, Cambridge, MA USA
[7] Thermo Fisher Sci, PPD, Philadelphia, PA USA
[8] Univ Zurich, Univ Zurich Hosp, Dept Gastroenterol & Hepatol, Zurich, Switzerland
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
26
引用
收藏
页码：116 / 117
页数：2
相关论文
共 50 条
  • [21] Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naive Inflammatory Bowel Disease Patients: Results from the EVOLVE Study
    Bressler, Brian
    Yarur, Andres
    Silverberg, Mark S.
    Bassel, Marielle
    Bellaguarda, Emanuelle
    Fourment, Chris
    Gatopoulou, Anthie
    Karatzas, Pantelis
    Kopylov, Uri
    Michalopoulos, George
    Michopoulos, Spyridon
    Navaneethan, Udayakumar
    Rubin, David T.
    Siffledeen, Jesse
    Singh, Andrew
    Soufleris, Konstantinos
    Stein, Dara
    Demuth, Dirk
    Mantzaris, Gerassimos J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (10): : 1694 - 1706
  • [22] Clinical Effectiveness and Safety of Vedolizumab in Patients With Crohn's Disease in China: Results From a Real World Study
    Kang, Chao
    Jie, Zhong
    Xie, Li
    Hu, Yaqiu
    Gianchetti, Lauren
    Khan, Zaeem
    Farhat, Zeinab
    Kamble, Pravin
    Xiang, Gao
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S813 - S814
  • [23] Clinical Effectiveness and Safety of Vedolizumab vs. Infliximab in Biologic-Naive Ulcerative Colitis Patients: A Brazilian Real-World Multicentric Observational Study
    Ferreira, S.
    Chebli, J. M. F.
    Parra, R.
    Sassaki, L. Yukie
    de Mello, M. K.
    Luporini, R. L.
    Chebli, L. A.
    Nobrega, F. J. Firmino
    da Silva, B. C.
    Dutra, R. D. M.
    Vasconcelos, J. R. de Oliveira
    Sales, M. P. Moraes
    Feres, O.
    Parente, J. M. L.
    Troncon, L. E. D. A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1087 - I1088
  • [24] Comparison of surgery rates in biologic-naive patients with Crohn's disease treated with vedolizumab or ustekinumab: findings from SOJOURN
    Vu, Michelle
    Ghosh, Sabyasachi
    Umashankar, Kandavadivu
    Weber, Laura
    Landis, Christina
    Candela, Ninfa
    Chastek, Benjamin
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [25] Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn's Disease Patients
    Garg, Rajat
    Aggarwal, Manik
    Butler, Robert
    Achkar, Jean Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin
    Qazi, Taha
    Rieder, Florian
    Regueiro, Miguel
    Click, Benjamin
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (07) : 3138 - 3147
  • [26] Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn’s Disease Patients
    Rajat Garg
    Manik Aggarwal
    Robert Butler
    Jean Paul Achkar
    Bret Lashner
    Jessica Philpott
    Benjamin Cohen
    Taha Qazi
    Florian Rieder
    Miguel Regueiro
    Benjamin Click
    Digestive Diseases and Sciences, 2022, 67 : 3138 - 3147
  • [27] Effectiveness and safety of ustekinumab in patients with Crohn's disease: a real-world experience
    Mohammad, D.
    Alshahrani, A.
    Bao, Y.
    Alramdan, R.
    Rajani, A.
    Chauhan, U.
    Salena, B.
    Tse, F.
    Greenwald, E.
    Albashir, S.
    Halder, S.
    Armstrong, D.
    Marshall, J.
    Narula, N.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S426 - S426
  • [28] Real-world clinical outcomes of biological therapy-naive patients with non-complicated Crohn's disease treated with vedolizumab: Results from the EVOLVE study
    Yarur, A.
    Mantzaris, G.
    Kopylov, U.
    Bassel, M.
    Brett, N.
    Kim, H.
    Lopez, C.
    Saha, S.
    Kifnidi, C.
    Agboton, C.
    Adsul, S.
    Demuth, D.
    Luo, M.
    Wang, S.
    Bressler, B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 121 - 121
  • [29] The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium
    Johnson, Amanda M.
    Barsky, Maria
    Ahmed, Waseem
    Zullow, Samantha
    Galati, Jonathan
    Jairath, Vipul
    Narula, Neeraj
    Peerani, Farhad
    Click, Benjamin H.
    Coburn, Elliot S.
    Dang, ThucNhi Tran
    Gold, Stephanie
    Agrawal, Manasi
    Garg, Rajat
    Aggarwal, Manik
    Mohammad, Danah
    Halloran, Brendan
    Kochhar, Gursimran S.
    Todorowski, Hannah
    Ud Din, Nabeeha Mohy
    Izanec, James
    Teeple, Amanda
    Gasink, Chris
    Muser, Erik
    Ding, Zhijie
    Swaminath, Arun
    Lakhani, Komal
    Hogan, Dan
    Datta, Samit
    Ungaro, Ryan C.
    Boland, Brigid S.
    Bohm, Matthew
    Fischer, Monika
    Sagi, Sashidhar
    Afzali, Anita
    Ullman, Thomas
    Lawlor, Garrett
    Baumgart, Daniel C.
    Chang, Shannon
    Hudesman, David
    Lukin, Dana
    Scherl, Ellen J.
    Colombel, Jean-Frederic
    Sands, Bruce E.
    Siegel, Corey A.
    Regueiro, Miguel
    Sandborn, William J.
    Bruining, David
    Kane, Sunanda
    Loftus, Edward V., Jr.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (02): : 317 - 328
  • [30] Effectiveness and Safety of Vedolizumab in Biologic-Naive Patients: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
    Macaluso, F.
    Fries, W.
    Renna, S.
    Viola, A.
    Muscianisi, M.
    Cappello, M.
    Guida, L.
    Siringo, S.
    Camilleri, S.
    Garufi, S.
    Privitera, A. C.
    Belluardo, N.
    Giangreco, E.
    Bertolami, C.
    Vassallo, R.
    Rizzuto, G.
    Orlando, R.
    Ventimiglia, N.
    Orlando, A.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S333 - S333
12345